[1]
“Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023007, Jan. 2023, doi: 10.4084/MJHID.2023.007.